The below clickable headlines link directly to outside media outlets, which featured UNC School of Medicine faculty starting Friday February 24, 2023.
Deep brain stimulation technology could improve dozens of conditions, researchers say – Dr. Flavio Frohlich (WPSD-TV)
OTC meds vs. allergy shots: A UNC doctor weighs in on NC’s early pollen season – Dr. Edwin Kim (The News & Observer)
Blood-Vessel-on-a-Chip Furthers Understanding of Vascular Malformations – Dr. Julie Blatt (Technology Networks)
Is the microbiome therapy hype up for a reckoning? – Dr. Sarah McGill (Pharmaceutical Technology)
Evan S. Dellon, MD: Limitations of Phase 3 Trial Data on Dupilumab – Dr. Evan S. Dellon (HCPLive)
Sublingual Immunotherapy Appears Viable in Treating Peanut Allergies in Kids – Dr. Edwin Kim (Knowledia)
RELIEF OF PARKINSON’S DISEASE SYMPTOMS WITH FOCUSED ULTRASOUND ABLATION – Dr. Vibor Krishna (ARCHYDE)
Some people on Ozempic lose the desire to drink. Scientists are asking why. – Dr. Janice Jin Hwang (The Indian Express)
Building a Better Opioid: Scientists Take Another Step Forward – Bryan L. Roth (PublicNewsTime)
Fact check: Were mask mandates really a ‘bust?’ UNC expert points out problems with study behind controversial NY Times column – Dr. Emily Sickbert-Bennett (WNCT-TV)
Lenacapavir Shows Efficacy as Long-Acting Agent in Combination Regimen For HIV – Dr. Joseph Eron (Pharmacy Times)
How does the brain age across the life span? New studies offer clues – Dr. Sahar Ahmad (The Seattle Times)
Novel peanut allergy treatment shown to be safe, effective and lasting – Dr. Edwin Kim (Medical Xpress)
The warning signs of an eating disorder – Dr. Cynthia Bulik (MSN Canada)